(Q38293779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

review article

1 reference

title

Mechanisms of initiation and progression of intestinal fibrosis in IBD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Vincenzo Flati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Jacopo Di Gregorio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Florian Rieder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Ian C Lawrance

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Gastroenterology

25 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

53-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523556%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology and natural history of inflammatory bowel diseases

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Crucial steps in the natural history of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Themes in fibrosis and gastrointestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Mechanisms of tissue remodeling in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Intestinal fibrosis in IBD--a dynamic, multifactorial process

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Fibrogenesis in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Crohn's disease complicated by strictures: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Cellular and molecular mechanisms of intestinal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Predictors of fibrostenotic Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Smad2 role in mesoderm formation, left-right patterning and craniofacial development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Hepatocyte growth factor in lung repair and pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

BMP-7 as antagonist of organ fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Decorin-TGFβ axis in hepatic fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Use of sirolimus (rapamycin) to treat refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Everolimus for refractory Crohn's disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Hedgehog-Gli pathway activation during kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Notch1 signaling in FIZZ1 induction of myofibroblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

A systems approach identifies HIPK2 as a key regulator of kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Serotonin has a key role in pathogenesis of experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Serotonin paracrine signaling in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Adipose tissue and inflammatory bowel disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Adiponectin receptors: a review of their structure, function and how they work

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Modulation of liver fibrosis by adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

BMP-7 counteracting TGF-beta1 activities in organ fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

The hippo signaling pathway in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

YAP regulates neuronal differentiation through Sonic hedgehog signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Klotho in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

SIRT1 inhibits the mouse intestinal motility and epithelial proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

MicroRNAs and the regulation of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

MicroRNAs in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Differential expression of collagen, MMP, TIMP and fibrogenic-cytokine genes in the granulomatous colon of Schistosoma mansoni-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Targeting matrix metalloproteinases in inflammatory conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Intestinal fibrosis in Crohn's disease: medical treatment or surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Treatment of inflammatory bowel diseases: to heal the wound or to heal the sick?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Outcome of medical treatment of stricturing and penetrating Crohn's disease: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Surgery for adult Crohn's disease: what is the actual risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863

The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.968863